The influence of certain arachidonic acid pathway inhibitors on central nervous system catecholamine level in rats administered with ethanol.
Lutnicki
K
K
Katedra i Zakład Patofizjologii Akademii Medycznej w Lublinie.
Szpringer
E
E
Wróbel
J
J
D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine / Q000494:pharmacology; D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism*; D016227:Benzoquinones / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D000431:Ethanol / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000378:metabolism*; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar
D016227:Benzoquinones; D004791:Enzyme Inhibitors; D007093:Imidazoles; D011725:Pyridines; D016718:Arachidonic Acid; D000431:Ethanol; D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; C036837:2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone; C037787:pirmagrel; D004298:Dopamine; D009638:Norepinephrine